The regulatory effect of MEF2C on a variety of malignancies has been widely studied, including its role in the regulation of iron death in meningioma (Bao et al., 2021) and its involvement in brain metastases of human breast cancer (Galego et al., 2021). Here, MEF2C is linked to breast cancer.